CI Investments Inc
AXSM icon

CI Investments Inc’s Axsome Therapeutics AXSM Stock Holding History

CI Investments Inc’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-885
Closed -$80K – 1308
2024
Q3 		$80K Buy
885
+7
+0.8% +$611 ﹤0.01% 909
2024
Q2 		$71K Sell
878
-233
-21% -$17.3K ﹤0.01% 900
2024
Q1 		$89K Buy
1,111
+1
+0.1% +$84 ﹤0.01% 922
2023
Q4 		$88K Buy
1,110
+310
+39% +$20.7K ﹤0.01% 862
2023
Q3 		$56K Sell
800
-24
-3% -$1.79K ﹤0.01% 940
2023
Q2 		$59K Buy
+824
New +$60.8K ﹤0.01% 915

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CI Investments Inc's AXSM Position: Q4 2024 in Review

CI Investments Inc sold out of Axsome Therapeutics (AXSM) in Q4 2024, closing a stake of 885 shares — an estimated $80K sold.

CI Investments Inc first reported a position in AXSM in Q2 2023 and held it in 6 quarters. The position peaked at $89K in Q1 2024. 292 funds tracked by Wall St. Rank hold AXSM as of Q4 2024.

  • CI Investments Inc reported no remaining Axsome Therapeutics position as of Q4 2024 after selling out during the quarter.
  • CI Investments Inc sold 885 Axsome Therapeutics shares in Q4 2024, an estimated $80K.
  • CI Investments Inc first reported a position in Axsome Therapeutics in Q2 2023 and held it in 6 quarters.
  • CI Investments Inc's Axsome Therapeutics position peaked at $89K in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2024.

Based on CI Investments Inc's 13F filing for Q4 2024, filed 12 Feb 2025.